SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-066319
Filing Date
2023-08-11
Accepted
2023-08-11 17:05:36
Documents
70
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_pasitheatherap.htm   iXBRL 10-Q 602741
2 OFFER OF EMPLOYMENT, DATED AS OF JUNE 21, 2022, BETWEEN PASITHEA THERAPEUTICS CO f10q0623ex10-1_pasitheathe.htm EX-10.1 65518
3 CERTIFICATION f10q0623ex31-1_pasitheathe.htm EX-31.1 10143
4 CERTIFICATION f10q0623ex31-2_pasitheathe.htm EX-31.2 10299
5 CERTIFICATION f10q0623ex32-1_pasitheathe.htm EX-32.1 4283
6 CERTIFICATION f10q0623ex32-2_pasitheathe.htm EX-32.2 4555
7 GRAPHIC ex10-1_001.jpg GRAPHIC 21369
  Complete submission text file 0001213900-23-066319.txt   4287683

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ktta-20230630.xsd EX-101.SCH 45372
9 XBRL CALCULATION FILE ktta-20230630_cal.xml EX-101.CAL 30961
10 XBRL DEFINITION FILE ktta-20230630_def.xml EX-101.DEF 209799
11 XBRL LABEL FILE ktta-20230630_lab.xml EX-101.LAB 442280
12 XBRL PRESENTATION FILE ktta-20230630_pre.xml EX-101.PRE 225326
64 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_pasitheatherap_htm.xml XML 465002
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40804 | Film No.: 231165096
SIC: 2834 Pharmaceutical Preparations